4-butyrolactone has been researched along with cubebin in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (33.33) | 29.6817 |
2010's | 7 (58.33) | 24.3611 |
2020's | 1 (8.33) | 2.80 |
Authors | Studies |
---|---|
Albuquerque, S; Bastos, JK; da Silva Filho, AA; da Silva, R; de Souza, GH; de Souza, VA; Donate, PM; e Silva, ML; Grando, MD; Montanheiro, M; Pereira, AC; Royo, Vde A; Saraiva, J | 1 |
de Pascoli, IC; Lopes, LM; Nascimento, IR | 1 |
Almeida, VA; Bastos, JK; Carvalho, TC; Coímbra, HS; Costa, ES; Cunha, WR; Filho, AA; Furtado, NA; Lima, TC; Martins, CH; Pereira, AC; Royo, VA; Silva, ML; Silva, R; Vinhólis, AH | 1 |
Dominguez, OP; Higuchi, Y; Horie, S; Ishikawa, T; Kumamoto, T; Matsumoto, K; Mochizuki, M; Nakanishi, W; Shimokawa, S; Tashima, K; Watanabe, T; Zhang, G | 1 |
Bastos, JK; Costa, ES; da Silva Ferreira, D; de Albuquerque, S; Esperandim, VR; Pereira, AC; Saraiva, J; Silva, ML | 1 |
Andrade E Silva, ML; Bastos, JK; Cunha, WR; da Silva Ferreira, D; de Albuquerque, S; Esperandim, VR; Saraiva, J; Sousa Rezende, KC | 1 |
Bastos, JK; Cunha, WR; da Silva Ferreira, D; de Albuquerque, S; e Silva, ML; Esperandim, VR; Rezende, KC; Saraiva, J | 1 |
Andrade e Silva, ML; Cunha, WR; Fontana, AC; Magalhães, LG; Mortensen, OV; Pereira, AC; Souza Rezende, KC; Timple, JM | 1 |
Andrade e Silva, ML; Barbosa, LC; Bastos, JK; Bertanha, HC; Costa, ES; Furtado, RA; Tavares, DC; Tomazella, IM | 1 |
Adfa, M; Koketsu, M; Ninomiya, M; Rahmad, R; Tanaka, K; Yudha S, S | 1 |
Andriani, KF; Bastos, JK; Borges, A; Borges, CHG; Caramori, GF; Conforti, VA; Cunha, WR; da Silva Laurentiz, R; de Andrade, CQJ; E Silva, MLA; Januário, AH; Lima, TC; Lucarini, R; Parreira, RLT; Pauletti, PM; Símaro, GV; Souza, AMP; Volpe, AC | 1 |
Ambrósio, SR; Braun, GH; de Souza, JM; Dias, GM; Januário, AH; Pauletti, PM; Pedroso, RCN; Pietro, RCLR; Pimenta, LP; Ramos, HP; Santos, MFC; Silva, MLA; Siqueira, KA; Soares, MA; Veneziani, RCS | 1 |
12 other study(ies) available for 4-butyrolactone and cubebin
Article | Year |
---|---|
Trypanocidal activity of (-)-cubebin derivatives against free amastigote forms of Trypanosoma cruzi.
Topics: 4-Butyrolactone; Animals; Benzodioxoles; Chagas Disease; Inhibitory Concentration 50; Lignans; Membrane Glycoproteins; Parasitic Sensitivity Tests; Protozoan Proteins; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma cruzi | 2005 |
Configurational analysis of cubebins and bicubebin from Aristolochia lagesiana and Aristolochia pubescens.
Topics: 4-Butyrolactone; Aristolochia; Circular Dichroism; Lignans; Magnetic Resonance Spectroscopy; Molecular Conformation; Plant Extracts; Plants, Medicinal | 2006 |
Evaluation of piper cubeba extract, (-)-cubebin and its semi-synthetic derivatives against oral pathogens.
Topics: 4-Butyrolactone; Anti-Infective Agents; Benzodioxoles; Candida albicans; Dioxoles; Enterococcus faecalis; Lignans; Microbial Sensitivity Tests; Piper; Plant Extracts; Streptococcus | 2007 |
Chemical constituents of Aristolochia constricta: antispasmodic effects of its constituents in guinea-pig ileum and isolation of a diterpeno-lignan hybrid.
Topics: 4-Butyrolactone; Animals; Aristolochia; Benzodioxoles; Dioxoles; Diterpenes; Ecuador; Guinea Pigs; Ileum; Lignans; Medicine, Traditional; Parasympatholytics; Plants, Medicinal; Stereoisomerism | 2008 |
Reduction of parasitism tissue by treatment of mice chronically infected with Trypanosoma cruzi with lignano lactones.
Topics: 4-Butyrolactone; Animals; Benzodioxoles; beta-Galactosidase; Chagas Disease; Chronic Disease; Dioxoles; Heart; Karyometry; Lactones; Lignans; Liver; Mice; Mice, Inbred BALB C; Spleen; Treatment Outcome; Trypanocidal Agents; Trypanosoma cruzi | 2010 |
In vivo infection by Trypanosoma cruzi: a morphometric study of tissue changes in mice.
Topics: 4-Butyrolactone; Animals; Antiprotozoal Agents; Benzodioxoles; Biometry; Cell Line; Chagas Disease; Dioxoles; Disease Models, Animal; Fibroblasts; Karyotyping; Lignans; Liver; Macaca mulatta; Male; Mice; Mice, Inbred BALB C; Spleen; Trypanosoma cruzi | 2013 |
Evaluation of the in vivo therapeutic properties of (-)-cubebin and (-)-hinokinin against Trypanosoma cruzi.
Topics: 4-Butyrolactone; Animals; Benzodioxoles; Chagas Disease; Dioxoles; Lignans; Male; Mice; Mice, Inbred BALB C; Nitroimidazoles; Piper; Trypanocidal Agents; Trypanosoma cruzi | 2013 |
The lignan (-)-hinokinin displays modulatory effects on human monoamine and GABA transporter activities.
Topics: 4-Butyrolactone; Attention Deficit Disorder with Hyperactivity; Benzodioxoles; Dioxoles; Dopamine; Dose-Response Relationship, Drug; GABA Plasma Membrane Transport Proteins; Humans; Lignans; Molecular Structure; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Serotonin Plasma Membrane Transport Proteins; Stereoisomerism | 2013 |
Chemopreventive effects of (-)-hinokinin against 1,2-dimethylhydrazine-induced genotoxicity and preneoplastic lesions in rat colon.
Topics: 1,2-Dimethylhydrazine; 4-Butyrolactone; Animals; Anticarcinogenic Agents; Benzodioxoles; Carcinogens; Colon; Comet Assay; Dimethylhydrazines; Dioxoles; DNA Damage; Lignans; Male; Molecular Structure; Piper; Rats; Rats, Wistar; Stereoisomerism | 2014 |
Antileukemic activity of lignans and phenylpropanoids of Cinnamomum parthenoxylon.
Topics: 4-Butyrolactone; Antineoplastic Agents, Phytogenic; Benzodioxoles; Cell Proliferation; Cinnamomum; HL-60 Cells; Humans; Lignans; Plant Extracts; U937 Cells | 2016 |
In vivo and in silico anti-inflammatory mechanism of action of the semisynthetic (-)-cubebin derivatives (-)-hinokinin and (-)-O-benzylcubebin.
Topics: 4-Butyrolactone; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzodioxoles; Catalytic Domain; Computer Simulation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyproheptadine; Dextrans; Dinoprostone; Dioxoles; Edema; Furans; Indomethacin; Ligands; Lignans; Male; Mice; Molecular Docking Simulation; Polysorbates; Rats, Wistar; Rutaceae | 2017 |
Optimization of (-)-cubebin biotransformation to (-)-hinokinin by the marine fungus Absidia coerulea 3A9.
Topics: 4-Butyrolactone; Absidia; Aquatic Organisms; Benzodioxoles; Biotransformation; Lignans; Seawater | 2021 |